EHS Promotional Activities System

Under the above EHS management system, the Health, Safety and Environment Committee promotes EHS activities through cooperation between labor and management, conducts education and training, ensuring occupational health and safety, and engaging in global environmental conservation efforts.

Environmental Management System (ISO 14001)

Production functions of the Chugai Group are handled by Chugai Pharma Manufacturing Co., Ltd., which has three unique plants. The three plants are: the Ukima Plant, which is a development-oriented plant in charge of manufacturing investigational drugs; the Utsunomiya Plant, which handles many functions from drug substances for biopharmaceuticals (antibody drugs) to formulation and packaging; and the Fujieda Plant, which aims to develop middle molecule drugs in addition to synthetic active pharmaceutical ingredients and solid oral formulations. All three of these plants have obtained ISO 14001 certification, which is the international standard for Environmental Management Systems (EMS), and they maintain and renew certification by undergoing external audits every year. For production sites that have a large impact on the environment due to their energy and resource consumption, we recognize that minimizing environmental risk by reducing their environmental impact, such as an appropriate use of resources, will at the same time help reduce management risk, and in such ways we are working to continuously improve our EMS.

Environment, Health and Safety (EHS) Audits

Since 2017, we have shifted to an integrated environment, safety and health (EHS) management structure in promoting our EHS activities. We conduct periodic internal EHS audits to verify that this EHS management system is functioning. These audits check EHS promotion systems and the status of their activities at business sites, the status of risk reduction in the event of environmental pollution or an occupational accident, and residual risk.

At the same time, companies are expected to work not only through their own activities but in cooperation with suppliers to help solve social issues such as growing poverty and inequality, environmental problems and worsening working environments. In response to these expectations, in November 2018, Chugai became a member of PSCI^*1, part of our efforts to build a comprehensive system for assessing suppliers. Based on the PSCI Principles^*2, in 2019 we established the Chugai Group Supplier Code of Conduct (SCC) setting forth standards of behavior expected of our suppliers. By conducting comprehensive assessments of suppliers and contractors based on the SCC – including their concern for the environment and human rights, ethics, labor, health, safety and compliance with related management systems – and working with them to practice continuous improvement, the Chugai Group aims to solve social issues throughout its entire supply chain.

• *1 The goal of the Pharmaceutical Supply Chain Initiative (PSCI) is to achieve and enhance a sustainable society. PSCI is a US-based non-profit organization with a membership of about 30 global pharmaceutical companies. It promotes uniform standards for supplier assessments and a platform for sharing information among procurement sources.
• *2 The PSCI Principles are codes of conduct for responsible supply chain management that set the standard for ethics, labor, health and safety, environment and related management systems. Supplier assessment standards incorporate, in addition to the PSCI Principles, international standards such as the UN Global Compact, the UN Guiding Principles on Business and Human Rights, the International Labor Organization (ILO) Declaration on Fundamental Principles and Rights at Work, and the ISO 14001 standard for environmental management systems.

For more information on the development of our comprehensive supplier evaluation system, please refer to the following page.

The Chugai Group is contributing to addressing climate-related issues by signing and participating in the following industry organizations and external initiatives.

United Nations Global Compact

The United Nations Global Compact is a UN-led initiative that promotes responsible corporate management based on 10 principles across four areas: human rights, labor, environment, and anti-corruption. Companies and organizations around the world voluntarily participate in this initiative to help realize a sustainable society.

Japan Climate Initiative (JCI)

Chugai has been participating in the Japan Climate Initiative (JCI), a network organization promoting climate change measures, since its launch in July 2018. As a non-state actor, Chugai declares its commitment to contributing to the realization of a decarbonized society in Japan.

<Examples of Endorsement of JCI Messages>>

• October 15, 2018: Japan Climate Action Summit Declaration
• February 4, 2020: JCI Message Calling for Enhanced Climate Measures
• January 18, 2021: Message on Renewable Energy Power Targets for FY2030
• April 21, 2021: Message on Greenhouse Gas Emission Reduction Targets for FY2030
• June 6, 2022: Message on Accelerating Renewable Energy Deployment
• April 12, 2023: Message on Tackling the Twin Crises through Renewable Energy and Carbon Pricing

https://japanclimate.org/ (Open in a new window)

https://japanclimate.org/english/ (Open in a new window)

Federation of Pharmaceutical Manufacturers’ Associations of Japan (FPMAJ)

Chugai participates in the Environmental Committee and the Carbon Neutral Action Plan Working Group of the Federation of Pharmaceutical Manufacturers’ Associations of Japan (FPMAJ), which consists of pharmaceutical manufacturers in Japan. Through these activities, Chugai promotes carbon neutrality efforts within Japan’s pharmaceutical manufacturing industry and contributes to the realization of a low-carbon society in Japan by reporting activities and making policy recommendations to the Japan Business Federation (Keidanren) and the Ministry of Health, Labour and Welfare.

http://www.fpmaj.gr.jp/ (Open in a new window)

http://www.fpmaj.gr.jp/en/fpmaj_HPenglish.pdf (Open in a new window)

Japan Pharmaceutical Manufacturers Association (JPMA)

Chugai also takes part in the Environmental Issues Review Committee of the Japan Pharmaceutical Manufacturers Association (JPMA), a member organization of FPMAJ composed of research-based pharmaceutical companies. The company formulates plans based on FPMAJ policies and works toward building a sustainable society.

TCFD

TCFD stands for the Taskforce on Climate-related Financial Disclosures. It was established by the Financial Stability Board in response to a request from G20 leaders in 2015 as a private-sector-led initiative to promote disclosure of climate-related financial information. In January 2020, Chugai expressed its support for the TCFD recommendations. Based on the TCFD framework, we are working to enhance our response to climate-related risks and opportunities and to further improve information disclosure, thereby strengthening the foundation for sustainable growth.

https://www.chugai-pharm.co.jp/english/sustainability/environment/tcfd.html

TNFD

TNFD stands for the Taskforce on Nature-related Financial Disclosures. It is an international initiative that aims to develop a framework for companies and financial institutions to assess and disclose nature-related risks and opportunities. In June 2025, we expressed our endorsement of the TNFD's recommendations, and we are working to address nature-related risks and opportunities and further enhance our disclosure based on the TCFD framework, aiming to visualize our dependence and impact on biodiversity and ecosystem services from a financial perspective.

https://www.chugai-pharm.co.jp/english/sustainability/environment/biodiversity/docs/TNFD_disclosures_report.pdf [PDF 1.0MB]

SBTi

SBTi (the Science Based Targets initiative) is an international initiative that promotes the setting of scientifically grounded targets for corporate climate action. It provides a framework for setting and validating greenhouse gas emission reduction targets aligned with the 1.5°C goal of the Paris Agreement and supports companies in their decarbonization efforts. Many companies around the world have joined the SBTi to strengthen their climate change initiatives. Chugai has set the following targets using FY2019 as the base year: 1. Reduce combined emissions from Scope 1 and Scope 2 by 60% by FY2030, and 2. Reduce Scope 3 emissions by 30%. As a longer-term goal, Chugai aims to achieve net-zero emissions for Scope 1 and Scope 2 by FY2050.

https://sciencebasedtargets.org/ (Open in a new window)

PSCI

PSCI (the Pharmaceutical Supply Chain Initiative) is a non-profit organization that aims to build a sustainable supply chain in the pharmaceutical industry. It promotes responsible procurement practices based on principles such as environmental protection, labor conditions, ethics, and human rights. Major pharmaceutical companies around the world participate in this initiative to jointly conduct supplier evaluations and capability-building efforts, working toward improving the sustainability of the entire industry. Chugai joined the PSCI in 2018 and has since been evaluating suppliers’ environmental conservation efforts and providing support based on its own experience when necessary.

https://pscinitiative.org/home (Open in a new window)

Our Approach to the Japan Government’s Decarbonization Goals

In an extraordinary session of the National Diet that Japan on October 26, 2020, Prime Minister Yoshihide Suga aims to achieve carbon neutrality and realize a decarbonized society by 2050. The Chugai Pharmaceutical Group directs the Japanese government’s declaration and supports the National Climate Change-related laws and regulations, the Energy Conservation Act and the Warming Act, and submits annual reports to the government on energy consumption, achievement of energy conservation targets, and greenhouse gas emissions. We support the response to the TCFD recommendations promoted by the government and conduct scenario analysis and disclose information.